AJMC October 29, 2025
Key Takeaways
- Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and patient-centered outcomes.
- Pharmacy and precision medicine operations are crucial, necessitating coordination between academic and community settings and integration of real-world evidence.
- Discussions emphasized the importance of pharmacy decision-making, precision medicine in lung cancer, and multidisciplinary collaboration for sustainable, high-value care.
- Timely biomarker and NGS testing, along with appropriate use of targeted and immunotherapeutic agents, are foundational to optimizing survival in lung cancer.
A session explores how value-based oncology integrates pharmacy, precision medicine, and real-world evidence to enhance lung cancer care and patient outcomes.
The transition toward value-based oncology care continues to challenge health systems to balance rapid clinical innovation with operational sustainability, equitable...
Today's Sponsors
Today's Sponsor